SCHEMBL493086

SCHEMBL493086

CN(C)C(c1ccc(F)cc1)C1CCC(CNC(=O)COCCN(C)S(=O)(=O)c2ccc(OC(F)(F)F)cc2)CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BDKRB1 P46663 1/20 0.42
CXCR3 P49682 1/20 0.42
DPP4 P27487 1/20 0.39
DPP7 Q9UHL4 1/20 0.39
PSEN1 P49768 1/20 0.38
PSEN2 P49810 1/20 0.38
SPPL2B Q8TCT7 1/20 0.38
SPPL2A Q8TCT8 1/20 0.38
APH1B Q8WW43 1/20 0.38
NCSTN Q92542 1/20 0.38
APH1A Q96BI3 1/20 0.38
PSENEN Q9NZ42 1/20 0.38
PTGIR P43119 1/20 0.37
HPGD P15428 1/20 0.37
HTT P42858 1/20 0.37
NPC1 O15118 1/20 0.37
TRPA1 O75762 5/20 0.36
KMT2A Q03164 1/20 0.36
MMP12 P39900 1/20 0.36
MAPT P10636 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL493590 0.93 BDKRB1 (0.42) BDKRB1CXCR3DPP4DPP7PSEN1
SCHEMBL492874 0.93 BDKRB1 (0.42) BDKRB1CXCR3DPP4DPP7PSEN1
SCHEMBL492782 0.93 CXCR3 (0.47) BDKRB1CXCR3DPP4DPP7PSEN1
SCHEMBL493538 0.93 HTT (0.40) PTGIRHPGDHTTNPC1TRPA1
SCHEMBL493379 0.92 KMT2A (0.44) CXCR3HPGDHTTNPC1KMT2A
SCHEMBL493168 0.91 CXCR3 (0.41) BDKRB1CXCR3DPP4DPP7PSEN1
SCHEMBL493378 0.90 KMT2A (0.43) PTGIRHPGDHTTNPC1TRPA1
SCHEMBL493439 0.89 L3MBTL1 (0.44) BDKRB1DPP4DPP7PSEN1PSEN2
SCHEMBL492871 0.89 ALDH1A1 (0.38) CXCR3PSEN1PSEN2APH1BNCSTN
SCHEMBL493376 0.89 ALDH1A1 (0.38) CXCR3PSEN1PSEN2APH1BNCSTN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8106055-B2 Substituted amide compounds GRUENENTHAL GMBH (DE) 2012-01-31 US claimed
EP-2139851-A2 SUBSTITUTED AMIDE DERIVATIVES Grünenthal GmbH (DE) 2010-01-06 EP claimed
US-20080306084-A1 Substituted Amide Compounds GRUENENTHAL GMBH (DE) 2008-12-11 US claimed
WO-2008131946-A2 SUBSTITUTED AMIDE DERIVATIVES Grünenthal GmbH (DE) 2008-11-06 WO claimed
US-8106055-B2 Substituted amide compounds GRUENENTHAL GMBH (DE) 2012-01-31 US disclosed
EP-2139851-A2 SUBSTITUTED AMIDE DERIVATIVES Grünenthal GmbH (DE) 2010-01-06 EP disclosed
US-20080306084-A1 Substituted Amide Compounds GRUENENTHAL GMBH (DE) 2008-12-11 US disclosed
WO-2008131946-A2 SUBSTITUTED AMIDE DERIVATIVES Grünenthal GmbH (DE) 2008-11-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080306084-A1 Substituted Amide Compounds OPRK1, NAA50, ACMSD BDKRB1 1622/4885CXCR3 4458/4885DPP4 877/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.